Related Experiment Video
Updated: Jan 8, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
miR-433 suppresses tumor progression via Smad2 in non-small cell lung cancer
Jianing Li1, Meng Chen2, Baiquan Yu1
1Department of Respiratory, The Second Affiliated Hospital of Harbin Medical University, China.
Abstract:
The role of transforming growth factor beta (TGF-β) in lung cancer is well known. TGF-β-mediated cellular proliferation and angiogenesis through similar to mothers against decapentaplegic homolog 2 (Smad2) protein has also been well elucidated. Smad2 is a predicted target for a microRNAs, namely miR-433. microRNAs are a significant class of non-coding RNAs which play an important role in epigenetic regulation. Here, we show that miR-433 directly binds to Smad2, which is shown to be upregulated in non-small cell lung carcinomas (NSCLC). miR-433 expression is downregulated in NSCLC tissues and cells. Overexpression of miR-433 is associated with decreased expression of proteins - namely Cyclin D1, MMP-2/TIMP-2, and MMP-9, and consequently reduced cell proliferation and invasion phenotypes. Complementation of miR-433 leads to rescue of these disrupted phenotypes. miR-433 mediates its action via Smad2 and Id-1. miR-433 may be a candidate worth further exploration for its prognostic and therapeutic potential in NSCLC.
Insights
MicroRNA-433 (miR-433) targets Smad2, a protein upregulated in non-small cell lung cancer (NSCLC). Restoring miR-433 expression inhibits cancer cell proliferation and invasion, suggesting its therapeutic potential in NSCLC.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- Transforming growth factor beta (TGF-β) signaling is implicated in lung cancer progression.
- Smad2 is a key mediator of TGF-β signaling and is upregulated in non-small cell lung carcinomas (NSCLC).
- MicroRNAs (miRNAs) are non-coding RNAs involved in epigenetic regulation and gene silencing.
Purpose of the Study:
- To investigate the role of miR-433 in NSCLC.
- To determine if miR-433 directly targets Smad2.
- To explore the therapeutic potential of miR-433 in NSCLC.
Main Methods:
- Luciferase reporter assays to confirm direct binding of miR-433 to Smad2.
- Western blotting to assess protein expression levels (Smad2, Cyclin D1, MMP-2/TIMP-2, MMP-9, Id-1).
- Cell proliferation and invasion assays in NSCLC cells with miR-433 overexpression or complementation.
Main Results:
- miR-433 directly binds to and downregulates Smad2 expression in NSCLC.
- miR-433 expression is decreased in NSCLC tissues and cells.
- Overexpression of miR-433 reduces cell proliferation and invasion by decreasing Cyclin D1, MMP-2/TIMP-2, and MMP-9 levels, mediated via Smad2 and Id-1.
Conclusions:
- miR-433 acts as a tumor suppressor in NSCLC by targeting Smad2.
- Restoration of miR-433 expression can inhibit NSCLC cell proliferation and invasion.
- miR-433 holds potential as a prognostic biomarker and therapeutic target for NSCLC.
Related Concept Videos
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation

